NCT00107393View on ClinicalTrials.gov

Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

November 30, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

capecitabine

Trial Locations (10)

802-0077

Kitakyushu Municipal Medical Center, Fukuoka

734-8551

Hiroshima University Hospital, Hiroshima

003-0804

Hokkaido Cancer Center, Hokkaido

216-8511

Saint Marianna University School of Medicine, Kanagawa

540-0006

National Hospital Organization - Osaka National Hospital, Osaka

553-0003

Osaka Kosei Nenkin Hospital, Osaka

565-0871

Osaka University Graduate School of Medicine, Osaka

980-8574

Tohoku University Graduate School of Medicine, Sendai

104-8560

St. Luke's International Hospital, Tokyo

998-8585

Sakata Municipal Hospital, Yamagata

All Listed Sponsors
lead

Tohoku University

OTHER

NCT00107393 - Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter